You have 9 free searches left this month | for more free features.

JNJ-55308942

Showing 1 - 25 of 420

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bipolar Disorder Trial in Worldwide (JNJ-55308942, Placebo)

Recruiting
  • Bipolar Disorder
  • JNJ-55308942
  • Placebo
  • Huntsville, Alabama
  • +45 more
Aug 17, 2022

Healthy Trial in Leuven (JNJ-55308942, [18F]-JNJ-64413739)

Completed
  • Healthy
  • Leuven, Belgium
    UZ Leuven Gasthuisberg
Jan 18, 2019

Healthy Trial in Merksem (JNJ-55308942 High Dose, JNJ-55308942 Low Dose, Levonorgestrel/Ethinyl Estradiol Fixed Dose combination

Completed
  • Healthy
  • JNJ-55308942 High Dose
  • +3 more
  • Merksem, Belgium
    Clinical Pharmacology Unit
Sep 27, 2018

Healthy Trial in Merksem (JNJ-55308942 0.5 mg, JNJ-55308942 1.5 mg, JNJ-55308942 4 mg)

Completed
  • Healthy
  • JNJ-55308942 0.5 mg
  • +8 more
  • Merksem, Belgium
    Clinical Pharmacology Unit
Apr 17, 2018

Advanced Prostate Cancer Trial in Lyon, Villejuif, Rotterdam (JNJ-78278343, JNJ-87189401)

Not yet recruiting
  • Advanced Prostate Cancer
  • Lyon, France
  • +2 more
Oct 18, 2023

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Healthy Trial in Lincoln (JNJ-68179280, Placebo)

Recruiting
  • Healthy
  • Lincoln, Nebraska
    Celerion
Jan 17, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (Abiraterone Acetate, Prednisone,

Active, not recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Los Angeles, California
  • +6 more
Jan 18, 2023

Metastatic Castration-resistant Prostate Tumors Trial in Australia, Korea, Republic of, United States (JNJ-78278343, Cetrelimab)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Neoplasms
  • Sarasota, Florida
  • +7 more
Apr 6, 2023

Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • (no location specified)
Nov 15, 2023

Tumors, Solid Tumor, Adult, Non-Hodgkin Lymphoma Trial in Worldwide (JNJ-64619178)

Active, not recruiting
  • Neoplasms
  • +3 more
  • Sarasota, Florida
  • +17 more
Jan 27, 2023

Healthy Trial in Leiden (JNJ-69095897, Placebo)

Recruiting
  • Healthy
  • Leiden, Netherlands
    Centre for Human Drug Research
Jan 31, 2023

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (JNJ-79635322)

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Edegem, Belgium
  • +16 more
Jan 27, 2023

Plaque Psoriasis Trial in United States (JNJ-77242113, Placebo)

Recruiting
  • Plaque Psoriasis
  • Rolling Meadows, Illinois
  • +8 more
Oct 18, 2023

Multiple Myeloma Trial in Japan, United States (JNJ-68284528)

Completed
  • Multiple Myeloma
  • JNJ-68284528
  • Phoenix, Arizona
  • +20 more
Oct 5, 2022

Healthy Trial in Merksem (JNJ-67835989, Placebo)

Completed
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Jul 20, 2022

Tumor Trial in Chuo-Ku, Kashiwa (JNJ-63723283, Erdafitinib)

Completed
  • Neoplasm
  • Chuo-Ku, Japan
  • +1 more
Nov 3, 2022

Plaque Psoriasis Trial (JNJ-77242113, JNJ-77242113 Matching Placebo, Deucravacitinib)

Not yet recruiting
  • Plaque Psoriasis
  • (no location specified)
Nov 16, 2023

Carcinoma, Non-small-Cell Lung Trial in New York, Fairfax (JNJ-86974680, Cetrelimab, Radiation Therapy)

Recruiting
  • Carcinoma, Non-small-Cell Lung
  • New York, New York
  • +1 more
Nov 8, 2023

Colitis, Ulcerative Trial (JNJ-77242113, Placebo)

Not yet recruiting
  • Colitis, Ulcerative
  • (no location specified)
Sep 15, 2023

Tumors Trial in Israel, Spain (JNJ-78306358)

Recruiting
  • Neoplasms
  • Haifa, Israel
  • +4 more
Aug 11, 2022

Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)

Recruiting
  • Geographic Atrophy
  • Macular Degeneration
  • Phoenix, Arizona
  • +3 more
Mar 31, 2023

Plaque Psoriasis Trial in United States (JNJ-77242113, Placebo)

Recruiting
  • Plaque Psoriasis
  • Rolling Meadows, Illinois
  • +6 more
Oct 18, 2023

Leukemia, Myeloid, Acute Trial in Worldwide (JNJ-75276617, Venetoclax (VEN), Azacitidine (AZA))

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +30 more
Aug 11, 2022